Single HCC smaller than 2 cm: Surgery or ablation? Surgeon's perspective

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 4, 2010, Pages 422-424

  Takayama, Tadatoshi ^a   Makuuchi, Masatoshi ^b   Hasegawa, Kiyoshi ^c  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROGNOSIS; RADIOFREQUENCY ABLATION; TUMOR VOLUME; CANCER STAGING; CATHETER ABLATION; CLINICAL TRIAL; COMPARATIVE STUDY; DECISION MAKING; LIVER TUMOR; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PROSPECTIVE STUDY; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DECISION MAKING; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; JAPAN; LIVER NEOPLASMS; NEOPLASM STAGING; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79952108873     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-009-0239-7     Document Type: Article

References (10)

1. Takayama T, Makuuchi M, Hirohashi S, et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology. 1998;28:1241-6. (Pubitemid 28493833)
2. Kojiro M, Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis. 2005;25:133-47.
3. Takayama T, Makuuchi M, Kojiro M, et al. Early hepatocellular carcinoma: pathology, imaging, and therapy. Ann Surg Oncol. 2008;15:972-8.
4. Hasegawa K, Makuuchi M, Takayama T, et al. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol. 2008;49:589-94.
5. Matsui O, Kadoya M, Kameyama T, et al. Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology. 1991;178:493-7.
6. Burns PN, Wilson SR. Focal liver masses: enhancement patterns on contrast-enhanced images, concordance of US scans with CT scans and MR Imaging. Radiology. 2006;242:162-74. (Pubitemid 44956021)
7. Holland AE, Hecht EM, Hahn WY, et al. Importance of small (≤20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology. 2005;237:938-44. (Pubitemid 41636384)
8. Livraghi T, Meloni F, Morabito A, et al. Multimodal image-guided tailored treatment of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center. Liver Transpl. 2004;10:S98-106.
9. Todo S, Furukawa H. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg. 2004;240:451-61. (Pubitemid 39121339)
10. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for hepatocellular carcinoma. Ann Surg. 2006;243:321-8. (Pubitemid 43327762)